Special report: behavioral marketing trends for pharma brands
Produced by MM+M and sponsored by AllazoHealth, this free special report offers a deep dive into how recent innovations in behavioral marketing and economics empower pharma marketers. You’ll learn about how behavioral insights shape strategy and messaging to spur both…
Election 2020: The impact on medication adherence
This year's election could have a major effect on adherence rates. Here are some possible changes in healthcare policy that could be enacted under Trump or Biden, and the impact on adherence. Revocation of the ACA In November, the Supreme…
Case study: Leading pharma brand achieves 4.6x increased days on therapy
Overcoming an adherence challenge This case study shows how a leading pharmaceutical company used AI to optimize engagement in their patient support program. The program saw 15 additional days on therapy compared to non-AI targeting, as well as 5 times…
Medicare Part D success story: Enhanced Medication Therapy Management
The current model for medication therapy management (MTM), under Medicare Part D, is based on a set of minimum performance standards that all participating plans must meet to qualify for payment. However this model incentivizes plans to offer a minimum…
Solving polypharmacy non-adherence
Polypharmacy, the simultaneous use of multiple drugs, is becoming more common as the population ages. More than 30% of older adults in the United States take five or more drugs, typically for multiple chronic conditions. How polypharmacy contributes to non-adherence…
Adherence: Learning from patient psychology
Barriers to medication adherence can take the form of social determinants such as housing, employment and access to pharmacies – and systemic barriers such as pre-approvals, multiple prescriptions and affordability. But psychological barriers also play a major role. Understanding these…
Trending: COVID-19 accelerates healthcare tech
Chronic disease patients benefit from telehealth pilot With COVID-19 closing physicians’ offices and preventing patients from in-person appointments, healthcare organizations have substantially increased use of telehealth. One group of patients that has benefited from the COVID-19-driven rush to telehealth are…
How technology is optimizing medication synchronization
When patients have multiple prescriptions, especially for long term conditions, refill dates often are not aligned and create barriers to adherence. So, pharmacies have been integrating medication synchronization programs into their workflow. Medication synchronization enables patients to fill all their…
Pharma and physician partnerships: Overcoming barriers
Pharmaceutical companies have aspired to make medication adherence programs more effective for years. A report from Credit Suisse shows that increased adherence could substantially increase revenue from 2020–2026 for leading pharma companies such as Merck, Pfizer, Bristol Myers Squibb, Johnson…
Case study: How a leading pharmacy improved both cost efficiency and effectiveness of patient interventions
Find out how a national retail pharmacy used artificial intelligence (AI) to generate a 2.3 times uplift in medication adherence. At the same time they improved targeting of dual patient interventions to make them more cost-effective. Making dual interventions for…
Implementing KPIs to track adherence progess towards brand goals
Are you measuring what matters most for your brand? Many key performance indicators (KPIs) are used to measure the success of adherence programs, and they can vary across different pharmaceutical companies. According to Andrea Kasprzyk, Director of Sales at AllazoHealth,…
Trending: Payers increase focus on social determinants of health
Improved understanding about the effect of social determinants of health (SDOH) on population health outcomes have spurred increased innovation from payers. Social determinants of health are the conditions where patients live, learn, work and play. Key SDOH areas include employment,…
How pharma is advancing medication adherence
We live in exciting times for adherence, and the pharma industry is playing a critical role, according to Mark Degatano, a pharmaceutical industry analytics expert who is on the advisory board of AllazoHealth. Degatano’s expertise comes from 24 years with…
Payer quality ratings: 7 best practices
Are you responsible for improving your plan’s quality ratings? Learn how to improve your performance on Star and other quality measures. Download our deck and get specific advice for payers on: The influence of population mix on performance Which patients…
Trending: Pharma increases use of real-world data to support products
Eli Lilly and Co. and Abbott have made headlines recently for using real-world evidence to prove better adherence and outcomes for its diabetes products. More pharma companies are likely to utilize real world data to support brands as access improves.…
Social determinants of health: Delivering value with AI
Payers, pharmacies and pharmaceutical companies are starting to join providers in recognizing that social determinants of health (SDOH) have a major impact on patient adherence and clinical outcomes. Healthcare organizations now face the challenge of finding ways to analyze and…
Pharma marketers: Four keys to a successful medication adherence program
With medication non-adherence costing the industry more than $600 billion a year, many pharmaceutical companies are creating medication adherence programs, often in conjunction with pharmacists and payers. According to Andrea Kasprzyk, Director of Sales at AllazoHealth, "The objective of an…
How pharmacies can make adherence cost-effective
Incentives drive pharmacy focus on adherence As pharmacies are increasingly held to quality incentives, they are getting proactive about adherence. For example, in March 2019, Walgreen Co. started hiring pharmacists specifically tasked with helping chronic disease patients to become more…
New patient data rules might offer opportunities for payers
Starting next year payers may have new opportunities to collect real world data that was previously fragmented, incomplete and in some cases unavailable. According to the rules going into effect January 1, 2021 by the U.S. Department of Health and…
Pharma study shows benefit of copay assistance for high-cost prescriptions
Besides being a financial issue for pharmaceutical companies, unfilled prescriptions can lead to poorer health outcomes, drive up overall cost of care, and can have an impact on provider performance under value-based payment models. Pharmaceutical companies often use copay assistance…
AllazoHealth names pharmacy benefits management leader Greg Watanabe to advisory board
AllazoHealth, a company that uses artificial intelligence to help pharmaceuticals, payers, and pharmacies improve medication adherence and quality outcomes, announced that pharmacy benefits management executive Greg Watanabe will be joining the company’s Advisory Board. Mr. Watanabe has a distinguished career…
Smart pill bottles: New study shows improved adherence interventions
A smart pill bottle platform improved adherence and patient satisfaction among a small sample of multiple myeloma patients, according to a paper in the November 2019 issue of the Journal of Managed Care & Specialty Pharmacy. The study was conducted…
Dispelling the myths of artificial intelligence in healthcare
As common as artificial intelligence has become in our daily lives — from Google’s Alexa, to Facebook's data-driven ads, to Waze's application of driver data to find the best route — it is little understood. The public tends to…
Study with large regional payer demonstrates 5.5x greater adherence uplift using AI
Partnering with Blue Cross Blue Shield of North Carolina on a randomized control trial, AllazoHealth demonstrated a 5.5 times uplift in adherence compared with traditional programs. In addition, the study showed our artificial intelligence (AI) engine delivered over 97%…
COVID-19: Surveys show payers intensifying patient outreach
What do payers consider as they grapple with the medication access and adherence needs of at-risk patients during the Covid-19 pandemic? Experts at McMann Managed Markets and Syneos Health surveyed their proprietary payer advisory boards to find out. Payers respond…
Changes to SUPD in the COVID-19 era
Even in the midst of COVID-19 concerns and changes in healthcare practice, payers and pharmacies need to continue to be focused on the CMS Star quality care measures. One measure in particular, the Part D “Statin Use for Persons with…
Artificial intelligence study demonstrates a 52% uplift in patient adherence indicators
AllazoHealth, a company that uses artificial intelligence (AI) to help enterprise healthcare companies improve medication adherence and quality outcomes, has released a new study demonstrating the impact of AI on patient adherence indicators. The poster outlining the study was published…
The impact of COVID-19 on quality measures: the new reality
On March 26, 2020, the Centers for Medicare and Medicaid Services (CMS) published an Interim Final Rule with comment period (IFC) on policy and regulatory revisions in response to the COVID-19 pandemic. Payers, PBMs and pharmacies need to be…
AllazoHealth names pharmaceutical industry analytics expert Mark Degatano to advisory board
AllazoHealth, a company that uses artificial intelligence to help pharmaceuticals, payers, and pharmacies improve medication adherence and quality outcomes, announced today that pharmaceutical industry veteran Mark Degatano will be joining the company’s Advisory Board. Mr. Degatano has over 35 years…
Latest trends in healthcare AI: Pharmacies, payers, and pharma
Here's a survey of how pharmacies, payers, and pharmaceutical companies are using artificial intelligence right now. Pharmacies: Personalizing care, making better decisions A May 2019 article in the American Journal of Health-System Pharmacy, “Using artificial intelligence in health-system pharmacy practice:…
AI for patient adherence: Buy vs. build
Highlights from a conversation with William Grambley, Chief Operating Officer at AllazoHealth. Got questions? William can be reached at william.grambley@allazohealth.com Many healthcare organizations are turning to artificial intelligence to uplift patient adherence. And these organizations are all asking the same…
Making the most of DIR contracts: Where to invest and why
Highlights from a conversation with William Grambley, Chief Operating Officer at AllazoHealth. Got questions? William can be reached at william.grambley@allazohealth.com DIR (Direct and Indirect Remuneration) contracts are very diverse. However, there is one common element: the expectation from payers/PBMs that…
AI-optimized pharma patient support program drives adherence
A leading pharmaceutical company engaged AllazoHealth on a multi-year project using artificial intelligence to optimize a patient support program for a major product. Overcoming an adherence challenge The pharmaceutical company faced a challenge: An estimated 50% of patents stopped taking…
Artificial intelligence for pharmacies: Achieving adherence measures and optimizing DIR contracts
Pharmacies can use artificial intelligence to make adherence improvements that meet the goals of their payer contracts, specifically the ones known as DIR (direct and indirect remuneration). When it comes to getting reimbursements, adherence plays a key role in…
Claims data compared: pharmacy, payer, PBM, provider, pharma
Highlights from a conversation with Linda Schultz, VP, Client Success at AllazoHealth. Got questions? Linda can be reached at linda.schultz@allazohealth.com When it comes to the AllazoHealth AI engine, the quality of outcomes rely on a diverse data set from…
Adherence interventions and artificial intelligence: an overview
Medication adherence is the biggest problem that healthcare keeps beating its collective head against. We have heard the numbers. US Pharmacist, in January 2018, cited statistics that nonadherence can account for up to 50% of treatment failures, around 125,000 deaths,…
Bowling with AllazoHealth!
The AllazoHealth team at last week’s bowling event. It was part of our 2020-21 planning & innovation all-hands meeting in NYC.
The coming revolution of AI analytics: Better outcomes, better scores, better reimbursement
As our Medicaid health plan clients tell us, it’s a numbers game. When it comes to reimbursement, states evaluate the performance of plans using the National Care Quality Alliance’s HEDIS and other endorsed measurements. But making measurable improvements to performance…
11th Annual Medicaid Innovations Forum
Medicaid managed care plans: Achieve targeted HEDIS measures with improved adherence powered by AI Connect with AllazoHealth, February 5-7, 2020 Medicaid Innovations Forum | Hyatt Regency Grand Cypress | Orlando, Florida The Medicaid Innovations Forum is a highly anticipated annual event…
38th Annual J.P. Morgan Healthcare Conference
Healthcare Investors: Make AI your priority at the 38th Annual J.P. Morgan Healthcare Conference Connect with AllazoHealth, January 13–16, 2020 Westin St. Francis Hotel | San Francisco, California The annual J.P. Morgan Healthcare Conference is the largest and most informative…
Healthcare AI: Why defining constraints upfront is critical
AllazoHealth COO William Grambley explains in this article: "You need to be explicit about AI program constraints upfront. Otherwise you can get to unintended consequences." "Future of Medicine with Artificial Intelligence," Biosupply Trends Quarterly, Fall 2019. Read article here
RISE Star Ratings Master Class: December 12 – 13, 2019
Join Allazo at RISE Star Ratings Master Class December 12 - 13, 2019, Omni La Costa Resort & Spa, Carlsbad, CA Join AllazoHealth at the RISE Star Ratings Master Class. The program offers Medicare Advantage plans a deep dive into…
Meet us in Miami! Join AllazoHealth at the Fifth Medicare Star Ratings & Quality Assurance Summit
Meet us in Miami! Join AllazoHealth at the Fifth Medicare Star Ratings & Quality Assurance Summit December 2–4, 2019 at the Hilton Miami Downtown, Miami FL AllazoHealth will be in attendance along with 20 top-rated Medicare Advantage plans who’ll be…